Kraig Biocraft Laboratories, Inc - FORM 10-K - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - March 22, 2017

Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Kraig Biocraft Laboratories, Inckblb_ex311.htm
10-K - PRIMARY DOCUMENT - Kraig Biocraft Laboratories, Inckblb201610k.htm
 
EXHIBIT 32.1
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
 
In connection with the accompanying Annual Report on Form 10-K of Kraig Biocraft Laboratories, Inc. for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kim Thompson, President, Chief Executive Officer and Chief Financial Officer of Kraig Biocraft Laboratories, Inc. hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
 
1.
The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
 
2.
The information contained in the Report fairly represents in all material respects, the financial condition and results of operations of Kraig Biocraft Laboratories, Inc.
 
Date: March 22, 2017
 
 
 
 
 
 
 
/s/ Kim Thompson
 
Kim Thompson
President, Chief Executive Officer and Chief Financial Officer (principal executive officer, principal financial officer and principal accounting officer)
 
 
A signed original of this written statement required by Section 906 has been provided to Kraig Biocraft Laboratories, Inc. and will be retained by Kraig Biocraft Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 

Kraig Biocraft Laboratories, Inc Reports